beyond ldl: assessing and treating residual ascvd risk | marc-andre cornier, md
Published 3 years ago • 503 plays • Length 1:02:00Download video MP4
Download video MP3
Similar videos
-
1:01
transforming copd care: nebulized exosomes for lung regeneration and improved patient outcomes
-
20:22
the experts insight on advanced non- small cell lung cancer- dr. cristian buono
-
5:52
trigenics cases: frozen shoulder, spinal stenosis, degenerative disc disease and osteoarthritis
-
12:37
structural heart disease interventions – beyond tavr
-
22:25
complex case 2: good, bad, ugly (ross reul, md)
-
39:52
natural defense mechanisms and downside of current cad therapies
-
3:46
battling relapsed diffuse large b-cell lymphoma (dlbcl) - sam's story
-
5:08
chapter 2: the effectiveness of lowering ldl cholesterol to prevent heart disease
-
0:31
defying the odds
-
8:55
treatment of unresectable locally advanced nsclc
-
1:39
treatment for patients with locally advanced unresectable nsclc - targeted therapies in lung cancer
-
0:56
a new era in the discovery of als treatments
-
35:09
moving beyond conventional care for dlbcl
-
1:31
outpatient total shoulder replacement with dr. paul mclendon
-
4:53
unravelling mysteries of heart ageing - part 1
-
8:06
a matter of the heart: vernal’s heart transplant surgery
-
1:20
dr. cowan on treatment strategies in transplant eligible- and -ineligible myeloma
-
16:45
management & optimization of patient awaiting transplant - d. cruz, md, phd | 2019 nffs symposium
-
1:50
is alectinib an option for patients with dctn1 alk disease?- targeted therapies in lung cancer 2023
-
37:37
episode 1: outliers change the world
-
2:41
dickson’s story: his bone marrow transplant journey
-
3:30
a case of unresectable locally advanced nsclc